Based on our data, we would propose that the increased LCN2 levels, partly as a result of neutrophil expansion and increased expression of Lcn2 during cachexia, partially explain the increased morbidity and mortality outcomes of cancer patients through its effects on caloric intake and subsequent lean and fat mass wasting. The gene discussed is LCN2; the disease is Cachexia.